129 related articles for article (PubMed ID: 18505072)
1. Association of the myeloperoxidase polymorphism with the risk of gastric cancer.
Hsu PI; Jwo JJ; Yang CL; Hsu PN; Yang HB; Lai KH; Chen IS; Chuah SK; Wu DC; Chen A
Anticancer Res; 2008; 28(2B):1317-23. PubMed ID: 18505072
[TBL] [Abstract][Full Text] [Related]
2. Association of the myeloperoxidase -463G-->A polymorphism with development of atrophy in Helicobacter pylori-infected gastritis.
Roe I; Nam S; Kim J; Shin J; Bang W; Yang M
Am J Gastroenterol; 2002 Jul; 97(7):1629-34. PubMed ID: 12135010
[TBL] [Abstract][Full Text] [Related]
3. Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer.
Chen A; Li CN; Hsu PI; Lai KH; Tseng HH; Hsu PN; Lo GH; Lo CC; Lin CK; Hwang IR; Yamaoka Y; Chen HC
Aliment Pharmacol Ther; 2004 Jul; 20(2):203-11. PubMed ID: 15233701
[TBL] [Abstract][Full Text] [Related]
4. Association of myeloperoxidase -463 G/A polymorphism with clinical outcome of Helicobacter pylori infection in Iranian patients with gastrointestinal diseases.
Kamali-Sarvestani E; Farsiani H; Shamoon Pour M; Bazargani A; Lankarani K; Taghavi AR; Saberifiroozi M
Iran J Immunol; 2007 Sep; 4(3):155-60. PubMed ID: 17767014
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese.
Sugimoto M; Furuta T; Shirai N; Kodaira C; Nishino M; Ikuma M; Sugimura H; Hishida A
Carcinogenesis; 2007 Sep; 28(9):2036-40. PubMed ID: 17389608
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.
Taguchi A; Ohmiya N; Shirai K; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2487-93. PubMed ID: 16284368
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism in chemokine CCL22 and susceptibility to Helicobacter pylori infection-related gastric carcinoma.
Wang G; Yu D; Tan W; Zhao D; Wu C; Lin D
Cancer; 2009 Jun; 115(11):2430-7. PubMed ID: 19298002
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
[TBL] [Abstract][Full Text] [Related]
9. Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients.
Hnatyszyn A; Szalata M; Stanczyk J; Cichy W; Slomski R
Exp Mol Pathol; 2010 Jun; 88(3):388-93. PubMed ID: 20230816
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between an insertion-deletion polymorphism in the pepsinogen C gene and gastric cancer as well as its precursors].
Sun LP; Guo XL; Zhang Y; Chen W; Bai XL; Liu J; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3059-63. PubMed ID: 17288837
[TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A
J Gastroenterol Hepatol; 2007 Sep; 22(9):1443-9. PubMed ID: 17716348
[TBL] [Abstract][Full Text] [Related]
12. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
[TBL] [Abstract][Full Text] [Related]
13. RANTES promoter genotype and gastric cancer risk in a Japanese population.
Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Hirata I; Arisawa T
Anticancer Res; 2009 Oct; 29(10):4265-9. PubMed ID: 19846984
[TBL] [Abstract][Full Text] [Related]
14. Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.
Jiang Z; Zhang Z; Wang Z; Zhang G; Hu K; He B; Wang S
Hepatogastroenterology; 2012 May; 59(115):757-61. PubMed ID: 22094928
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymorphisms in the 3'-untranslated region (3'-UTR) of VEGF gene on gastric pre-malignant condition.
Tahara T; Arisawa T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Takahama K; Watanabe M; Nakano H; Hirata I
Anticancer Res; 2009 Feb; 29(2):485-9. PubMed ID: 19331191
[TBL] [Abstract][Full Text] [Related]
16. Association of the myeloperoxidase -468G-->A polymorphism with gastric inflammation and duodenal ulcer risk.
Hsu PI; Jwo JJ; Tseng HH; Lai KH; Lo GH; Lo CC; Wu CJ; Chuah SK; Hwang IR; Chen JL; Chen YS; Chen A
World J Gastroenterol; 2005 May; 11(18):2796-801. PubMed ID: 15884126
[TBL] [Abstract][Full Text] [Related]
17. Germline variations of the MALT1 gene as risk factors in the development of primary gastric B-cell lymphoma.
Hellmig S; Bartscht T; Fischbach W; Ott SJ; Rosenstiel P; Klapper W; Fölsch UR; Schreiber S
Eur J Cancer; 2009 Jul; 45(10):1865-70. PubMed ID: 19394813
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
Kaise M; Miwa J; Suzuki N; Mishiro S; Ohta Y; Yamasaki T; Tajiri H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):139-45. PubMed ID: 17272999
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer.
Stec-Michalska K; Peczek L; Krakowiak A; Michalski B; Chojnacki J; Knopik-Dabrowicz A; Klupinska G; Nawrot B
J Gastroenterol Hepatol; 2008 Mar; 23(3):424-9. PubMed ID: 17683502
[TBL] [Abstract][Full Text] [Related]
20. Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis.
Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H; De la Cruz V
Oncol Rep; 2008 Jan; 19(1):223-8. PubMed ID: 18097599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
